Whitepaper
15 Apr 2022

Clinical Study Liposomal Curcumin

PDF 726 kB

Liposomal Curosome Curcumin 500 mg (250mg curcumin) per dosage of 25 ml of CureSupport Nederland B.V. Zutphenseweg 55, Deventer are found to be 16.73 times more bioavailable than the reference product Non Liposomal Curcumin 500 mg (250 mg curcumin) per dosage of 25 ml of CureSupport Nederland B.V. Zutphenseweg 55, Deventer. In healthy, adult, human subjects under fasting conditions.

Study No: SLS-CT-0006-17
This bioavailability study is performed by Bio Agile Therapeut.


Content provided by our supplier

CureSupport Nederland B.V.

  • NL
  • 2022
    On CPHI since
  • 50 - 99
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Wholesale/Retail

Other Content from CureSupport Nederland B.V. ()